Literature DB >> 15719173

Association, mutual stabilization, and transcriptional activity of the STRA13 and MSP58 proteins.

A V Ivanova1, S V Ivanov, M L Lerman.   

Abstract

STRA13 is a hypoxia-inducible bHLH transcription factor implicated in the pVHL/HIF, TGF-beta, and Jak/STAT pathways. To further characterize the STRA13 protein-interacting network and mechanisms of STRA13-dependent transcription, we utilized yeast two-hybrid screening. Here we report on STRA13 interaction with the cell cycle-associated transcription factor MSP58. We demonstrated that the basic domain of STRA13 and the FHA domain of MSP58 are essential for this association. We performed phospho-peptide mapping of both MSP58 and STRA13 and showed that their association was modulated by the STRA13 phosphorylation status. STRA13/MSP58 complex formation protected both proteins from the proteasome-mediated degradation, extending their half-lives considerably. STRA13 and MSP58 synergistically co-operated in the STRA13 promoter-driven transcription repression. Both proteins were co-localized in the nucleus and showed transcript accumulation during the S phase of the cell cycle. Thus, we characterize a novel STRA13-associated transcription repression complex and provide a link between cell cycle regulation and STRA13 activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15719173     DOI: 10.1007/s00018-004-4423-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  36 in total

1.  Prevalence and predictors of left atrial thrombus in patients with atrial fibrillation: is transesophageal echocardiography necessary before cardioversion?

Authors:  Rahul Malik; Daniel M Alyeshmerni; Zuyue Wang; Steven A Goldstein; Rebecca Torguson; Joseph Lindsay; Ron Waksman; Itsik Ben-Dor
Journal:  Cardiovasc Revasc Med       Date:  2014-12-27

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.

Authors:  Morten Lock Hansen; Rikke Malene H G Jepsen; Jonas Bjerring Olesen; Martin Huth Ruwald; Deniz Karasoy; Gunnar Hilmar Gislason; Jim Hansen; Lars Køber; Steen Husted; Christian Torp-Pedersen
Journal:  Europace       Date:  2014-09-17       Impact factor: 5.214

4.  Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutter.

Authors:  Maura M Zylla; Mara Pohlmeier; Alexander Hess; Derliz Mereles; Meinhard Kieser; Thomas Bruckner; Eberhard Scholz; Edgar Zitron; Patrick A Schweizer; Hugo A Katus; Dierk Thomas
Journal:  Am J Cardiol       Date:  2014-12-18       Impact factor: 2.778

5.  Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.

Authors:  Seiji Habara; Keigo Dote; Masaya Kato; Shota Sasaki; Kenji Goto; Hiroaki Takemoto; Daiji Hasegawa; Osamu Matsuda
Journal:  Eur Heart J       Date:  2007-08-22       Impact factor: 29.983

6.  B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Authors:  Rami Doukky; Heather Gage; Vijaiganesh Nagarajan; Anna Demopoulos; Marek Cena; Enrique Garcia-Sayan; George J Karam; Rasa Kazlauskaite
Journal:  Echocardiography       Date:  2013-03-15       Impact factor: 1.724

7.  Predictors of left atrium appendage clot detection despite on-target warfarin prevention for atrial fibrillation.

Authors:  F Zoppo; G Brandolino; A Berton; N Frigato; M Michieletto; A Zanocco; F Zerbo; E Bacchiega; A Lupo; E Bertaglia
Journal:  J Interv Card Electrophysiol       Date:  2012-08-07       Impact factor: 1.900

8.  Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation.

Authors:  D Y Leung; I W Black; G B Cranney; A P Hopkins; W F Walsh
Journal:  J Am Coll Cardiol       Date:  1994-09       Impact factor: 24.094

9.  Estimation of left atrial blood stasis using diastolic late mitral annular velocity.

Authors:  Masaharu Masuda; Katsuomi Iwakura; Koichi Inoue; Atsunori Okamura; Yasushi Koyama; Yuko Toyoshima; Nobuaki Tanaka; Hiroyuki Nakanishi; Yohei Sotomi; Issei Komuro; Kenshi Fujii
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-11-08       Impact factor: 6.875

Review 10.  Epidemiology of atrial fibrillation: European perspective.

Authors:  Massimo Zoni-Berisso; Fabrizio Lercari; Tiziana Carazza; Stefano Domenicucci
Journal:  Clin Epidemiol       Date:  2014-06-16       Impact factor: 4.790

View more
  13 in total

1.  PTEN induces apoptosis and cavitation via HIF-2-dependent Bnip3 upregulation during epithelial lumen formation.

Authors:  Y Qi; J Liu; S Saadat; X Tian; Y Han; G-H Fong; P P Pandolfi; L Y Lee; S Li
Journal:  Cell Death Differ       Date:  2014-11-14       Impact factor: 15.828

2.  Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.

Authors:  Wei Lin; Xiao-Ming Li; Jing Zhang; Yi Huang; Jiang Wang; Jian Zhang; Xiao-Fan Jiang; Zhou Fei
Journal:  Med Oncol       Date:  2013-08-31       Impact factor: 3.064

3.  The novel interaction between microspherule protein Msp58 and ubiquitin E3 ligase EDD regulates cell cycle progression.

Authors:  Mario Benavides; Lai-Fong Chow-Tsang; Jinsong Zhang; Hualin Zhong
Journal:  Biochim Biophys Acta       Date:  2012-10-12

4.  Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex.

Authors:  Weizhong Chang; Aileen M Barnes; Wayne A Cabral; Joann N Bodurtha; Joan C Marini
Journal:  Hum Mol Genet       Date:  2009-10-21       Impact factor: 6.150

5.  TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.

Authors:  Meenakshi Bhansali; Jun Zhou; Lirim Shemshedini
Journal:  Mol Endocrinol       Date:  2015-12-09

6.  Expression of MSP58 in hepatocellular carcinoma.

Authors:  Ming Zhong; Xi Zhang; Bing Li; Chang-sheng Chen; Gen-lin Ji; Shi-xing Li; Dan-qing Bi; Qing-chuan Zhao; Hai Shi
Journal:  Med Oncol       Date:  2013-03-22       Impact factor: 3.064

7.  Expression of MSP58 in human colorectal cancer and its correlation with prognosis.

Authors:  Hai Shi; Shu-Jun Li; Bo Zhang; He-Liang Liu; Chang-Sheng Chen
Journal:  Med Oncol       Date:  2012-07-08       Impact factor: 3.064

8.  Identification and characterization of nuclear and nucleolar localization signals in 58-kDa microspherule protein (MSP58).

Authors:  Chuan-Pin Yang; Chi-Wu Chiang; Chang-Han Chen; Yi-Chao Lee; Mei-Hsiang Wu; Yi-Huan Tsou; Yu-San Yang; Wen-Chang Chang; Ding-Yen Lin
Journal:  J Biomed Sci       Date:  2015-05-16       Impact factor: 8.410

9.  RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.

Authors:  Wei Lin; Jing Zhang; Jian Zhang; Xinping Liu; Zhou Fei; Xia Li; Laetitia Davidovic; Zhuo Tang; Lan Shen; Yanchun Deng; Angang Yang; Hua Han; Xiang Zhang; Libo Yao
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

10.  58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathway.

Authors:  Che-Chia Hsu; Yi-Chao Lee; Shiu-Hwa Yeh; Chang-Han Chen; Chih-Ching Wu; Tsui-Ying Wang; Yu-Nong Chen; Liang-Yi Hung; Yao-Wen Liu; Han-Ku Chen; Yi-Ting Hsiao; Wei-Sheng Wang; Jen-Hui Tsou; Yi-Huan Tsou; Mei-Hsiang Wu; Wen-Chang Chang; Ding-Yen Lin
Journal:  J Biol Chem       Date:  2012-05-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.